Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Contreras Jaime
2. Date of Event Requiring Statement (Month/Day/Year)
09/16/2013
3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ABT]
(Last)
(First)
(Middle)
100 ABBOTT PARK ROAD
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Senior Vice President
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ABBOTT PARK, IL 60064
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common shares without par value 23,733
D
 
Common shares without par value 20 (1)
I
Profit Sharing Trust
Common shares without par value 63,903 (2)
I
Jaime Contreras Marvan 2006 Living Trust
Common shares without par value 2,066 (3)
I
By spouse
Common shares without par value 16 (4)
I
Profit Sharing Trust (by spouse)
Common shares without par value 12,081 (5)
I
Living Trust (by spouse)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) (6) 02/15/2009 02/14/2018 Common shares 11,300 $ 26.7 D  
Option (right to buy) (6) 02/15/2010 02/14/2018 Common shares 11,300 $ 26.7 D  
Option (right to buy) (6) 02/15/2011 02/14/2018 Common shares 11,300 $ 26.7 D  
Option (right to buy) (6) 02/20/2010 02/19/2019 Common shares 5,900 $ 26.02 D  
Option (right to buy) (6) 02/20/2011 02/19/2019 Common shares 5,900 $ 26.02 D  
Option (right to buy) (6) 02/20/2012 02/19/2019 Common shares 5,900 $ 26.02 D  
Option (right to buy) (7) 02/19/2011 02/18/2020 Common shares 4,467 $ 26.19 D  
Option (right to buy) (7) 02/19/2012 02/18/2020 Common shares 4,466 $ 26.19 D  
Option (right to buy) (7) 02/19/2013 02/18/2020 Common shares 4,467 $ 26.19 D  
Option (right to buy) (7) 02/18/2012 02/17/2021 Common shares 5,767 $ 22.39 D  
Option (right to buy) (7) 02/18/2013 02/17/2021 Common shares 5,766 $ 22.39 D  
Option (right to buy) (7) 02/18/2014 02/17/2021 Common shares 5,767 $ 22.39 D  
Option (right to buy) (7) 02/17/2013 02/16/2022 Common shares 7,334 $ 27.03 D  
Option (right to buy) (7) 02/17/2014 02/16/2022 Common shares 7,333 $ 27.03 D  
Option (right to buy) (7) 02/17/2015 02/16/2022 Common shares 7,333 $ 27.03 D  
Option (right to buy) (7) 07/15/2013 02/19/2014 Common shares 21,108 $ 33.37 D  
Option (right to buy) (7) 02/15/2014 02/14/2023 Common shares 19,934 $ 34.94 D  
Option (right to buy) (7) 02/15/2015 02/14/2023 Common shares 19,933 $ 34.94 D  
Option (right to buy) (7) 02/15/2016 02/14/2023 Common shares 19,933 $ 34.94 D  
Option (right to buy) (7) 08/20/2013 02/19/2014 Common shares 1,545 $ 35.08 D  
Option (right to buy) (3) (6) 07/20/2008 07/19/2017 Common shares 1,034 $ 25.76 I By spouse
Option (right to buy) (3) (6) 07/20/2009 07/19/2017 Common shares 1,033 $ 25.76 I By spouse
Option (right to buy) (3) (6) 07/20/2010 07/19/2017 Common shares 1,033 $ 25.76 I By spouse
Option (right to buy) (3) (6) 02/15/2009 02/14/2018 Common shares 1,067 $ 26.7 I By spouse
Option (right to buy) (3) (6) 02/15/2010 02/14/2018 Common shares 1,067 $ 26.7 I By spouse
Option (right to buy) (3) (6) 02/15/2011 02/14/2018 Common shares 1,066 $ 26.7 I By spouse
Option (right to buy) (3) (7) 08/20/2013 02/19/2014 Common shares 2,715 $ 35.08 I By spouse

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Contreras Jaime
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064
      Senior Vice President  

Signatures

John A. Berry, by power of attorney for Jaime Contreras 09/26/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Balance in the Abbott Laboratories Stock Retirement Trust as of 9/16/13.
(2) Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
(3) The reporting person disclaims beneficial ownership of all securities held by his spouse.
(4) Balance held by spouse in the Abbott Laboratories Stock Retirement Trust as of 9/16/13. The reporting person disclaims beneficial ownership of these securities.
(5) Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
(6) Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
(7) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.